Invention Grant
- Patent Title: Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid
-
Application No.: US14006414Application Date: 2012-03-19
-
Publication No.: US09636350B2Publication Date: 2017-05-02
- Inventor: Matthew Krayenbuhl
- Applicant: Matthew Krayenbuhl
- Applicant Address: CH Pully CH Belmont-sur-Lausanne CH Epalinges
- Assignee: Matthew Krayenbuhl,Antonio Dos Santos,Michael Kenyon
- Current Assignee: Matthew Krayenbuhl,Antonio Dos Santos,Michael Kenyon
- Current Assignee Address: CH Pully CH Belmont-sur-Lausanne CH Epalinges
- Agency: Nixon & Vanderhye P.C.
- Priority: EP11159067 20110321
- International Application: PCT/IB2012/051310 WO 20120319
- International Announcement: WO2012/127407 WO 20120927
- Main IPC: A61K31/58
- IPC: A61K31/58 ; A61K9/00 ; A61K9/12 ; A61K45/06 ; A61K31/47 ; A61K31/56 ; A61K31/575 ; A61K31/496 ; A61K31/573
Abstract:
The invention relates to a pharmaceutical composition of unit dose for inhalation by a human subject comprising a topical corticoid and a quinolone or fucidic acid, characterized in that the ratio of the weight of the topical corticoid to the weight of the quinolone or fucidic acid is between 0.02 and 20 and the amount of quinolone or of fucidic acid is less than 1 mg. This composition can be administered by nasal spray and is used for treating the upper and lower respiratory tract, in particular sinusitis and nasal polyps.
Public/Granted literature
Information query
